AMGN · Healthcare
Amgen Inc
24/100
Smart-money confidence1 of 3 sources positive
Bearish — money moving out
No standout activity across the feeds we track.
Hedge funds
32
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$225.5B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NasdaqGS
About AMGEN INC
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients…
Who's behind the signal
Every informed buyer we can see on AMGN, across all three feeds.
Hedge funds · 6
Millennium Management (Englander)
Increased +240%
Gotham Asset Mgmt (Greenblatt)
Increased +91%
D.E. Shaw & Co
Increased +514%
Citadel Advisors
Increased +54%
Bridgewater Associates (Dalio)
Increased +389%
AQR Capital Management
Decreased −30%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 50 on record
Disclosures from 2014-07-10 to 2025-04-15
The newest disclosure we hold for this stock is 2025-04-15.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2025-04-15 | Tommy Tuberville · R-AL | Senate | Sold | $15,001 - $50,000 |
| 2022-09-26 | Earl Blumenauer · D-OR | House | Bought | $1,001 - $15,000 |
| 2022-05-11 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-03-14 | Earl Blumenauer · D-OR | House | Sold | $1,001 - $15,000 |
| 2022-03-03 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-02-24 | Earl Blumenauer · D-OR | House | Bought | $1,001 - $15,000 |
| 2022-02-22 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2022-02-17 | John H. Rutherford · R-FL | House | Sold | $1,001 - $15,000 |
| 2022-02-11 | Earl Blumenauer · D-OR | House | Bought | $1,001 - $15,000 |
| 2021-07-19 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
Show the other 40
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2021-04-30 | Kathy E. Manning · D-NC | House | Bought | $1,001 - $15,000 |
| 2021-03-04 | Carol D. Miller · R-WV | House | Bought | $15,001 - $50,000 |
| 2021-02-16 | Peter Meijer · R-MI | House | Sold | $1,001 - $15,000 |
| 2021-02-05 | Kurt Schrader · D-OR | House | Bought | $1,001 - $15,000 |
| 2021-01-15 | Kathy E. Manning · D-NC | House | Sold | $1,001 - $15,000 |
| 2020-10-22 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2020-10-08 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2020-07-28 | Carol D. Miller · R-WV | House | Bought | $15,001 - $50,000 |
| 2020-05-29 | John A. Yarmuth · D-KY | House | Sold | $1,001 - $15,000 |
| 2020-05-15 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2020-05-01 | Earl Blumenauer · D-OR | House | Bought | $1,001 - $15,000 |
| 2020-04-07 | Kelly Loeffler · R-GA | Senate | Sold | $250,001 - $500,000 |
| 2020-04-07 | Kelly Loeffler · R-GA | Senate | Bought | $15,001 - $50,000 |
| 2020-03-09 | Bill Cassidy · R-LA | Senate | Sold | $1,001 - $15,000 |
| 2020-03-04 | Kelly Loeffler · R-GA | Senate | Sold | $15,001 - $50,000 |
| 2020-02-20 | Mikie Sherrill · D-NJ | House | Sold | $1,001 - $15,000 |
| 2020-01-14 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2020-01-09 | Mike Gallagher · R-WI | House | Sold | $1,001 - $15,000 |
| 2019-02-04 | Jack Reed · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2018-12-07 | Bill Cassidy · R-LA | Senate | Sold | $1,001 - $15,000 |
| 2018-04-24 | Shelley Moore Capito · R-WV | Senate | Bought | $1,001 - $15,000 |
| 2018-04-05 | Shelley Moore Capito · R-WV | Senate | Bought | $1,001 - $15,000 |
| 2018-03-09 | Jack Reed · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2017-06-15 | Patty Murray · D-WA | Senate | Sold | $1,001 - $15,000 |
| 2017-05-30 | James M. Inhofe · R-OK | Senate | Sold | $50,001 - $100,000 |
| 2017-05-24 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2017-04-05 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2017-03-16 | Patty Murray · D-WA | Senate | Bought | $1,001 - $15,000 |
| 2017-01-20 | John Hoeven · R-ND | Senate | Sold | $50,001 - $100,000 |
| 2016-12-23 | Sheldon Whitehouse · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2016-11-28 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2016-11-23 | John Hoeven · R-ND | Senate | Bought | $50,001 - $100,000 |
| 2016-10-31 | Bill Cassidy · R-LA | Senate | Bought | $1,001 - $15,000 |
| 2016-05-24 | Sheldon Whitehouse · D-RI | Senate | Bought | $15,001 - $50,000 |
| 2016-04-12 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2015-05-27 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2015-03-10 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2015-02-20 | Jack Reed · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2014-12-18 | Sheldon Whitehouse · D-RI | Senate | Bought | $15,001 - $50,000 |
| 2014-07-10 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
Not a model pick — but on our radar.
AMGEN INC isn't in the top-10 model right now, but 6 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
6
Investors
0
New positions
5
Increasing
1
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+240%
0.1% of Millennium Management's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+91%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+514%
0.1% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+54%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
+389%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−30%
0.0% of AQR Capital Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to AMGEN INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell AMGEN INC or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime